InsiderClue
Insiders · Profile

Krempa David

Chief Business Officer at Eton Pharmaceuticals. Filing since 12 Jun 2025. CIK 0001968254

Company
Date
Role
Action
Shares
Amount
Of holding
ETON Eton Pharmaceuticals, Inc.
6 Oct 2026
Chief Business Officer
Sold at will
4,166
$229.41K
8.8%
ETON Eton Pharmaceuticals, Inc.
24 Aug 2026
Chief Business Officer
Sold at will
25,000
$1.63M
40.3%
ETON Eton Pharmaceuticals, Inc.
27 May 2026
Chief Business Officer
Sold at will
19,679
$619.37K
43.8%
ETON Eton Pharmaceuticals, Inc.
26 May 2026
Chief Business Officer
Sold at will
37,524
$1.18M
59.8%
ETON Eton Pharmaceuticals, Inc.
22 May 2026
Chief Business Officer
Sold at will
42,797
$1.43M
62.9%
ETON Eton Pharmaceuticals, Inc.
16 Jun 2025
Chief Business Officer
Sold at will
10,223
$150.58K
1.6%
ETON Eton Pharmaceuticals, Inc.
13 Jun 2025
Chief Business Officer
Sold at will
6,800
$100.44K
1.1%
ETON Eton Pharmaceuticals, Inc.
12 Jun 2025
Chief Business Officer
Sold at will
16,977
$253.30K
2.6%
8 decisions on file.